Heyland, D K <br/><br/>
Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective.  [electronic resource] 

 -  Journal of clinical epidemiology  Sep 2000 
 - 888-94 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0895-4356 
<br/><br/><label>Standard No.: </label>10.1016/s0895-4356(99)00214-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Decision Making<br/>Female<br/>Fibrinolytic Agents--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Patient Satisfaction<br/>Prospective Studies<br/>Risk Assessment<br/>Streptokinase--therapeutic use<br/>Thrombolytic Therapy<br/>Tissue Plasminogen Activator--therapeutic use